Healthcare providers frequently encounter cases where respiratory issues and mental health intersect. This nationwide study evaluated three analytical models to identify factors associated with pulmonary dysfunction-depression comorbidity. Consequently, the research aims to improve clinical outcomes and reduce the overall healthcare burden by providing better screening tools for clinicians. Identifying these co-occurring conditions early is essential for holistic patient management.

The study compared Logistic Regression (LR), Bayesian Network (BN), and Extreme Gradient Boosting (XGBoost). Initially, both LR and BN showed similar discrimination levels across different cohorts. Furthermore, these models exceeded the performance of XGBoost in validation. While XGBoost often captures non-linear patterns, it appeared miscalibrated in this specific longitudinal sample. Therefore, clinicians should choose models based on their intended clinical application and the need for sensitivity.

Stable Markers for Pulmonary Dysfunction-Depression Comorbidity

Researchers identified several consistent risk factors across all analytical methods. Specifically, psychiatric history emerged as the strongest predictor of depressive symptoms. Additionally, physical comorbidities such as nephropathy, arthritis, and gastropathy significantly increased patient vulnerability. Interestingly, body mass index (BMI) and household registration status showed an inverse association with the condition. These findings suggest that higher BMI might act as a protective factor in some chronic respiratory contexts, contrasting with its role in other metabolic diseases.

Choosing the Right Clinical Model

Model selection should align with the specific goals of the healthcare provider. For instance, BN and LR are preferable for sensitivity-forward screening because they identify more at-risk individuals. However, XGBoost may be reserved for high-threshold confirmatory decisions only after proper recalibration. Ultimately, integrating routinely available sociodemographic and clinical variables helps clinicians pinpoint vulnerable patients early. This proactive approach is vital for managing the complex needs of patients suffering from pulmonary dysfunction and mental health challenges.

Frequently Asked Questions

Which model is most effective for screening depression in pulmonary patients?

Bayesian Network (BN) and Logistic Regression (LR) models are generally better for screening due to their higher sensitivity and more reliable probability estimates compared to XGBoost in this context.

What are the primary risk factors for depression in these patients?

The strongest factors include a history of psychiatric illness, along with comorbid conditions like nephropathy, arthritis, and gastropathy. Factors like BMI often show an inverse relationship with depression risk in this population.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

Cheng Q et al. Comparative Performance of 3 Analytical Models in Identifying Associated Factors of Pulmonary Dysfunction-Depression Comorbidity: China Health and Retirement Longitudinal Study-Based Nationwide Cross-Sectional Study. JMIR Med Inform. 2026 Apr 09. doi: 10.2196/77940. PMID: 41955000.

Barua UK et al. Prevalence of depression and its risk factors among patients with chronic obstructive pulmonary disease in a tertiary level hospital in West Bengal, India. Indian J Med Res. 2012.

McCormick B. Patients With COPD and Anxiety or Depression Affected by Higher Clinical, Economic Burdens. AJMC. 2024.